Citi Pharma Limited, one of Pakistan’s leading pharmaceutical manufacturers, has announced its strategic entry into the real estate sector with the launch of a new Real Estate Investment Trust (REIT) subsidiary, marking a significant diversification of its business portfolio.
Read More: NCL Industries Limited Reports 87% Profit Surge in First Half of FY 2026
The newly established subsidiary will focus on acquiring, managing and developing income-producing real estate assets across Pakistan. This move expands Citi Pharma’s presence beyond healthcare and pharmaceutical manufacturing into property investment, unlocking new avenues for growth and long-term value creation.
Citi Pharma’s leadership highlighted that the creation of the REIT subsidiary represents a strategic response to evolving market opportunities and investor demand for diversified investment instruments. The REIT will target high-quality commercial and mixed-use properties aimed at generating stable rental income and capital appreciation.
The initiative reflects Citi Pharma’s commitment to broadening its business footprint while leveraging core strengths in financial management and corporate governance. By entering the real estate investment space through a regulated financial vehicle, the company aims to offer institutional and retail investors exposure to Pakistan’s growing property market.
Industry analysts noted that introducing a dedicated REIT subsidiary aligns with global investment trends, where real estate investment trusts have become an attractive asset class for investors seeking diversification, regular income and inflation-hedged returns. The launch is expected to attract new capital flows into the listed real estate sector.
Citi Pharma’s board emphasised that the real estate venture will operate with a strong focus on transparency, regulatory compliance and prudent asset selection. The company plans to prioritise properties in prime locations with strong demand characteristics and long-term growth potential.
The new REIT subsidiary is poised to strengthen Citi Pharma’s overall market positioning while contributing to broader development within Pakistan’s real estate investment landscape. The initiative underscores the company’s forward-looking strategy to expand into high-growth sectors and generate sustainable returns for shareholders.
